Brief: Coeptis Therapeutics Announces Phase 1 Data On DVX201 For Covid-19 Treatment Has Been Accepted For Publication In Molecular Therapy Methods And Clinical Development
07/11/2024 13:08
Nov 7 (Reuters) - Coeptis Therapeutics Holdings Inc
COEP.O :
* COEPTIS THERAPEUTICS ANNOUNCES PHASE 1 DATA ON DVX201 FOR
COVID-19 TREATMENT HAS BEEN ACCEPTED FOR PUBLICATION IN
MOLECULAR THERAPY METHODS AND CLINICAL DEVELOPMENT
Source text: ID:nPn6yjmXXa
Further company coverage: COEP.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Z Squared (Delaware)
See all newsBrief: Z Squared Inc. Signs Definitive Agreement To Acquire 100% Of Paradox Data And Its Union County Campus
Brief: Z Squared, Inc. To Acquire Majority Interest In Paradox Data And Its Union County Campus, A Next-Generation Data Center Development Targeting Up To 150 MW Of Firm Power
Brief: Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement To Support Ai Infrastructure Buildout
Brief: Z Squared Appoints Jon Najarian, Pete Najarian, Marc Lopresti And Jay Zapata To Newly Formed Advisory Board
Brief: Z Squared Announces Executive Leadership Appointments To Advance Ai Infrastructure Strategy